Category: Science Explained
Crocin and safranal are the two compounds that make saffron worth talking about beyond the kitchen. One carries the colour, the other the aroma, and together they are how a saffron extract is standardised and dosed. Here is what they are and what the evidence supports.
Category: Science Decoded | Reading time: ~8 min | Level: Intermediate
Saffron is the spice everyone knows as the expensive one, the threads that turn rice gold and cost more per gram than almost anything in the cupboard. What fewer people know is that in the last decade saffron quietly moved from the kitchen to the supplement shelf, sold not for flavour but for mood. And when it made that move, two chemical names came with it: crocin and safranal.
Those names are not marketing decoration. They are how you tell a serious saffron supplement from a sprinkle of overpriced dust. Crocin and safranal are the compounds that give saffron its colour and its scent, and they are also the yardsticks used to standardise and dose the extracts that clinical trials actually tested. Understanding them is how you read a saffron label properly, and how you keep a realistic view of what the evidence does and does not show.
Crocin and safranal are two of the main active compounds in saffron, the spice made from the dried stigmas of the Crocus sativus flower. Crocin is a carotenoid, a class of pigment molecule, and it is responsible for saffron's intense red-gold colour [4]. Safranal is a volatile aromatic compound, and it carries much of saffron's characteristic smell and part of its taste [4].
The single idea to hold onto is that these two are saffron's marker compounds. Researchers measure them to gauge how strong a batch of saffron or an extract is, and manufacturers standardise extracts against them so that each dose contains a known, consistent amount [4]. That is why molecules you would otherwise never think about show up on a supplement label: they are the handle by which saffron's potency is measured and made reproducible.
To see why crocin and safranal earn their place on a label, you have to appreciate how variable a botanical is. Raw saffron differs in potency from crop to crop, depending on where it grew, how it was stored and how it was processed. Weighing the saffron tells you the mass, not the strength, so two products with the same milligrams of saffron can deliver quite different amounts of active compound.
Standardisation solves this by fixing the extract to a defined content of chosen markers [4]. For saffron, crocin and safranal are the natural choices, because they are characteristic of the spice, measurable, and among the compounds studied for effects. A standardised saffron extract is manufactured so that each capsule delivers a set amount of these markers, which makes the dose meaningful and, crucially, comparable to the material used in trials.
This is not a saffron-specific trick. It is the same logic behind standardising any serious botanical: pick reliable markers, hold them constant, and the dose starts to mean something. Without it, a milligram figure is close to guesswork.
If you shop for saffron supplements you will keep meeting a particular name and a particular number: affron, at 28mg. Affron is a branded standardised saffron extract that has been used across a series of clinical studies of mood and emotional wellbeing, and many of those trials used a daily dose in the region of 28mg [3].
Two things are worth being precise about. First, the 28mg refers to the standardised extract, not to 28mg of pure crocin or safranal. The extract is defined by its content of those markers, and the dose is the amount of that defined material [3]. Second, the reason the figure recurs is simply that it is the dose the research used, so a product citing 28mg of a named standardised saffron extract is signalling an attempt to match the studied material and amount [3]. That is a more informative claim than a vague mention of saffron, because it ties the product to something that was actually tested.
Saffron is, by botanical standards, reasonably well studied for mood. Several small randomised controlled trials of standardised saffron extracts have reported benefits for mood-related and emotional wellbeing outcomes, and systematic reviews have pulled these together with cautiously positive conclusions [1][2][3]. Among plants marketed for mood, that puts saffron near the front of the pack.
But the honest grade is promising, not proven, and the reasons are specific. The trials tend to be small and relatively short. A number of them are linked to the manufacturers of the extracts being tested, which is a recognised source of bias even when the science is done carefully. And large, long, fully independent replications are still thin on the ground [1][2]. So the accurate description is that standardised saffron shows encouraging mood-related signals in a limited evidence base that needs strengthening, and that it is discussed in structure and function terms, supporting emotional wellbeing, never as a treatment for a diagnosed condition. A cautious grade here is not a dismissal, it is precision.
If saffron interests you, the marker compounds turn the label into useful information. Look for a named standardised extract, ideally one used in research such as affron, with a defined marker content and a studied dose in the region of 28mg per day [3]. A product that just says saffron, with no standardisation and no dose you can tie to a trial, tells you very little, and given how expensive and easily faked saffron is, it may not contain much genuine saffron at all.
Set realistic expectations on timing and scale. The mood-related trials typically run over several weeks, so this is not an overnight effect, and the evidence supports emotional wellbeing rather than promising to fix anything. If you take medication for mood, saffron is something to raise with a clinician rather than add on your own, because combining active botanicals with prescribed treatment deserves oversight. Our dedicated piece on saffron for mood goes through the studies in more depth.
At the doses used in supplements, standardised saffron extracts are generally well tolerated in trials, with mild headache or digestive upset among the more common complaints [1]. The picture changes at extremes: saffron in very high amounts, far above culinary or supplement doses, can be toxic, so more is emphatically not better here.
The clearest specific caution is pregnancy. High doses of saffron have traditionally been avoided in pregnancy because they have been associated with uterine effects, and that caution carries into supplement use [2]. Anyone pregnant should avoid saffron supplements, and anyone taking mood medication or other prescribed drugs should coordinate with a clinician before adding an active botanical, since these cautions come from the pharmacology and traditional evidence rather than from any single system flagging a specific pairing.
Pregnant, breastfeeding, or on medication? Check with a healthcare professional first.
Crocin and safranal are a good example of why we care about standardisation rather than just ingredient names. A supplement that ties itself to defined marker compounds at a studied dose is making a checkable claim, and one that simply says saffron is not. Our approach is to describe saffron's mood evidence as what it is, promising but limited, and to point to standardisation as the thing that separates a research-grade product from expensive filler.
If you want the detail, our piece on saffron for mood walks through the trials and their limits, our explainer on bioavailability covers why extract quality matters for what actually reaches you, and our guide to how we grade evidence explains why a promising-but-limited grade is a considered judgement, not a hedge. You can also browse the Remedy Library to see how we describe botanicals honestly.
1. Hausenblas HA, Saha D, Dubyak PJ, Anton SD (2013). Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomised clinical trials. Journal of Integrative Medicine, 11(6):377-383. PMID 24299602. Pooled small trials with cautiously positive mood findings. 2. Lopresti AL, Drummond PD (2014). Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action. Human Psychopharmacology, 29(6):517-527. PMID 25163440. Review noting encouraging results and evidence limitations. 3. Kell G, Rao A, Beccaria G, et al. (2017). affron, a novel saffron extract (Crocus sativus L.) improves mood in healthy adults over 4 weeks in a double-blind, parallel, randomised, placebo-controlled clinical trial. Complementary Therapies in Medicine, 33:58-64. Trial of a standardised extract at 28mg per day. 4. EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) (2021). Affron and increase in positive mood: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal, 19(5):6669. Characterises the standardised extract by its crocin and safranal content; concluded a cause-and-effect relationship for the mood claim was not established.
They are two of the key active compounds in saffron, the spice made from the dried stigmas of the Crocus sativus flower. Crocin is a carotenoid, a pigment molecule, and it gives saffron its intense red-gold colour. Safranal is a volatile aromatic compound and it carries much of saffron's characteristic smell and part of its taste. Together they are the compounds researchers most often measure and standardise saffron extracts against, which is why they appear on supplement labels rather than staying a kitchen curiosity.
Standardisation means the extract is manufactured to contain a defined, consistent amount of specific marker compounds, in this case crocin and safranal. Raw saffron varies in potency depending on the crop, so a standardised extract is adjusted so that each capsule delivers a known quantity of these markers. This makes the dose reproducible from batch to batch, which matters because the clinical studies were done on standardised material, not on random spice. A product standardised to the same markers at the same dose is the one most comparable to the research.
Affron is a branded standardised saffron extract that has been used in a number of clinical studies, particularly for mood and emotional wellbeing. Many of those trials used 28mg per day, which is why that figure recurs on labels. The 28mg refers to the standardised extract, not to 28mg of a single compound, and the extract is defined by its content of markers such as crocin and safranal. When a product cites 28mg of a named standardised saffron extract, it is signalling that it is trying to match the material and dose used in research.
There is genuine research interest, and several small randomised trials of standardised saffron have reported benefits for mood-related and emotional wellbeing outcomes. The honest grade is promising but limited: the studies tend to be small, relatively short, and some are linked to extract manufacturers, and larger independent trials are still needed. So saffron is one of the better-studied botanicals in this area without being a settled case, and it is described in structure and function terms, supporting emotional wellbeing, not as a treatment for any diagnosed condition.
At the doses used in supplements, standardised saffron extracts are generally reported as well tolerated in trials, with mild effects such as headache or digestive upset among the more common complaints. Saffron in very high amounts, far above culinary or supplement doses, can be toxic, and it has traditionally been avoided in pregnancy because high doses have been associated with uterine effects. As with any active botanical, sensible dosing, good sourcing and caution in pregnancy or alongside medication all matter.
Saffron is costly because each flower yields only a few stigmas and they are harvested by hand, making it one of the most expensive spices by weight. That expense creates a strong incentive for adulteration, where cheaper plant material or dyes are passed off as saffron or padded into extracts. For supplements this means sourcing and genuine standardisation matter more than usual, because a cheap saffron product may not contain the marker compounds it claims. A defined, tested, standardised extract is the safeguard against paying for something that is not really saffron.
Crocin is the pigment that colours saffron and, by extension, dishes cooked with it, and related crocin-type compounds are why saffron has long been used as a natural colouring. In supplements, though, crocin is of interest less as a dye and more as a marker of extract strength and a compound studied for biological effects. So the same molecule that colours a paella is the one measured to standardise a capsule, but the reason it appears on a supplement label is standardisation and research, not colour.
It matters quite a lot, given how expensive and easily adulterated saffron is. Without a named standardised extract and defined marker content, you cannot tell whether the product matches the material used in research or how much active compound it actually delivers. The clinical evidence rests on standardised extracts at specific doses, so a plain mention of saffron with no standardisation is much weaker information than a product citing a named extract standardised to crocin and safranal at a studied dose such as 28mg.
Because weight alone does not capture potency. Raw saffron varies in its content of active compounds depending on the crop, storage and processing, and adulteration is common. Measuring specific marker compounds such as crocin and safranal gives a consistent handle on strength, so that each dose in a trial, and ideally each capsule on a shelf, delivers a comparable amount of the compounds thought to matter. It is the same logic behind standardising any botanical: pick reliable markers so the dose means something.
It is worth taking seriously and worth reading with care. Several trials report encouraging mood-related results, which is a real signal, but a number are connected to extract manufacturers, the studies are often small and short, and independent replication is still limited. That does not make the findings worthless, it makes them promising rather than proven. The honest position is to treat saffron as one of the more interesting botanicals in this space while waiting for larger, longer, independent trials before drawing firm conclusions.